Team up with SGS for CDISC Open Rules implementation. As pioneers in developing the CDISC Open Rules, we've invested significant time and expertise in perfecting these rules. Ready to support you!
Integrating industry best practices, enhancing credibility with regulatory bodies and industry stakeholders.
The Open Rules framework encourages better data management practices resulting in cleaner, more consistent data. It also ensures seamless data sharing and collaboration across teams, partners, and vendors, improving efficiency in multi-sponsor studies or outsourcing models. Thereby, fostering a more effective and compliant research ecosystem.
As an early adopter of the CDISC Open Rules, our knowledge and expertise is officially recognized by CDISC.
Our expertise with the CDISC Open Rules helps streamline your processes, saving you time and resources.
From project scoping and expert advice to project implementation and resource support, we tailor our services to your needs.
As pioneers in the field, we are at the forefront of industry developments, enabling you to stay ahead of the curve.
Let SGS simplify your implementation process to ensure a smooth transition to the new emerging industry standard.
With a proven track record and unwavering commitment, we consistently deliver on our promises.
We ensure your data is compliant and submission-ready.
Glenn Borgmans
Business Development Manager
Marisa Wyckmans
Data management system and process manager, SGS
Our specialists have helped shape the CDISC Open Rules project from day one, serving as a trusted partner to CDISC. They combine hands-on expertise with practical support to make your implementation smooth and stress-free.
Chief Standards Officer, CDISC
Peter Van Reusel
It's exciting to see SGS taking a leading role as a key contributor and early adopter of this critical initiative.
"
We're a mid-sized, full-service CRO specialized in early-phase development and biometrics. We offer drug development consultancy, project management, monitoring, data management, statistics, medical writing, safety and regulatory services. We have our own clinical pharmacology unit in Belgium featuring a viral challenge facility and have access to patients through our site network with 400+ sites. Our key therapeutic areas include infectious diseases, vaccines, respiratory, dermatology and oncology.